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###### Means (±SD) of demographic, emotional and clinical variables in FMS patients and the control group.

For medication use and comorbid depression and anxiety disorders the corresponding numbers of participants (percentage in brackets) are displayed.
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                                                              FMS patients   Control group   F or ӽ^2^   *p*
  ----------------------------------------------------------- -------------- --------------- ----------- ----------
  Age (years)                                                 49.55 ± 8.42   47.03 ± 9.41    1.47        .229
  Body mass index (kg/m^2^)                                   26.52 ± 3.54   25.38 ± 4.51    1.50        .224
  Duration of education (years)                               12.11 ± 3.20   12.90 ± 3.55    1.01        .318
  Antidepressants (%)                                         21 (47.7%)     1 (3.2%)        18.53       \< .0001
  Anxiolytics (%)[\*](#t001fn002){ref-type="table-fn"}        24 (54.5%)     10 (32.3%)      4.44        .035
  Analgesics (%)                                              34 (77.3%)     5 (16.1%)       30.12       \< .0001
  Opioids (%)                                                 16 (36.4%)     0 (0%)          15.12       \< .0001
  Depression (SCID) (%)                                       20 (45.5%)     4 (12.9%)       9.74        .002
  Anxiety (SCID) (%)[\*\*](#t001fn003){ref-type="table-fn"}   21 (47.7%)     4 (12.9%)       10.90       .001
  Depression (BDI)                                            20.64±12.00    7.37±7.75       29.22       \< .0001
  Trait-anxiety (STAI-T)                                      35.36±8.88     19.38±9.91      53.50       \< .0001
  State-anxiety (STAI-S)                                      32.02±9.98     21.04±9.25      23.37       \< .0001
  Hypersomnia (OQSQ)                                          8.21±3.68      4.70±1.92       23.64       \< .0001
  Insomnia (OQSQ)                                             30.62±6.56     18.37±7.63      55.37       \< .0001
  Fatigue (FSS)                                               49.69±11.91    20.92±8.52      132.80      \< .0001
  Pain intensity (VAS)                                        3.60±.78       1.13±1.31       103.78      \< .0001
  Affective pain (MPQ)                                        5.98±4.82      1.27±1.63       27.34       \< .0001
  Total pain (MPQ)                                            53.76±32.29    18.23±11.90     30.81       \< .0001
  Physical HRQoL (SF-36)                                      38.44±9.04     65.79±4.33      243.77      \< .0001
  Mental HRQoL (SF-36)                                        33.79±9.18     54.41±8.92      93.93       \< .0001

*Note*. Results of group comparisons are reported (univariate ANOVAs or ӽ^2^ tests). SCID = Structured Clinical Interview for Axis I Disorders of the Diagnostic and Statistical Manual for Mental Disorders; STAI-T = State-Trait Anxiety Inventory Trait Scale; STAI-S = State-Trait Anxiety Inventory State Scale; BDI = Beck Depression Inventory; FSS = Fatigue Severity Scale; OQSQ = Oviedo Quality of Sleep Questionnaire; VAS = Visual Analog Scale; MPQ = McGill Pain Questionnaire; HRQoL = Health-Related Quality of Life; SF-36 = Short-Form Health Survey;

\* The use of anxiolytics in healthy controls was sporadic and mainly related to sleep problems.

\*\*Anxiety disorders comprised generalized anxiety disorder, panic disorder, phobias, and adjustment disorders.
